je.st
news
Exclusive: Pfizer is mystery bidder for rare disease drugmaker Sobi - sources
2015-04-30 19:21:27| Biotech - Topix.net
The Swedish company, known as Sobi, has a market value of 35.8 billion Swedish crowns . Its medicines for rare or "orphan" conditions make it a target in a consolidating sector in which large, cash-rich drugmakers seek to bolster their portfolios with offerings from smaller biotech firms.
Tags: sources
exclusive
disease
rare
Category:Biotechnology and Pharmaceuticals